Aug 10 2026 - Heron Therapeutics Announces Second Quarter 2026 Financial Results
Jul 27 2026 - Heron Therapeutics to Report Second Quarter 2026 Financial Results on Monday,...
Jun 2 2026 - U.S. District Court Issues Decision Regarding CINVANTI® Patents
May 11 2026 - Heron Therapeutics Announces First Quarter 2026 Financial Results and Reaffirms...
Thank you for submitting your request. A Heron Therapeutics representative will be in contact.
Instructions: This form is intended for use by trained CrossLink representatives regarding questions from US Medical Professionals only. Fields marked with an asterisk (*) are mandatory.
Unsolicited Medical Information Request for ZYNRELEF® (bupivacaine and meloxicam) extended-release solution
A signature will not be collected on this form.